Development of a Platform for Producing Recombinant Protein Components of Epitope Vaccines for the Prevention of COVID-19

A new platform for creating anti-coronavirus epitope vaccines has been developed. Two loop-like epitopes with lengths of 22 and 42 amino acid residues were selected from the receptor-binding motif of the Spike protein from the SARS‑CoV‑2 virus that participate in a large number of protein-protein in...

Descripción completa

Detalles Bibliográficos
Autores principales: Karyagina, Anna S., Gromov, Alexander V., Grunina, Tatyana M., Lyaschuk, Alexander M., Grishin, Alexander V., Strukova, Natalia V., Generalova, Maria S., Galushkina, Zoya M., Soboleva, Lyubov’ A., Dobrinina, Olga Yu., Bolshakova, Tatyana N., Subbotina, Marina E., Romanovskaya-Romanko, Ekaterina A., Krasilnikov, Igor V., Polyakov, Nikita B., Solovyev, Andrey I., Grumov, Daniil A., Zhukhovitsky, Vladimir G., Ryabova, Ekaterina I., Prokofiev, Vladimir V., Lunin, Vladimir G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pleiades Publishing 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527442/
https://www.ncbi.nlm.nih.gov/pubmed/34903153
http://dx.doi.org/10.1134/S0006297921100096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527442/
https://www.ncbi.nlm.nih.gov/pubmed/34903153
http://dx.doi.org/10.1134/S0006297921100096

Ejemplares similares